2024-11-20 - Analysis Report
## Procter & Gamble Co (PG) Stock Analysis Report

**1. Performance Comparison and Divergence:**

Procter & Gamble Co (PG) is a multinational consumer goods company that produces and markets a wide range of products.  The cumulative return of PG is 88.25%, while the S&P 500 (VOO) has a cumulative return of 125.6%.  This represents a difference of -37.35%.  The relative divergence of -37.35% places PG at the 12.9th percentile of its historical range of divergence from the S&P 500 (ranging from -48.29% to 36.51%).  This suggests that PG's underperformance relative to the S&P 500 is significant but not entirely unusual within its historical context.  The provided CAGR data shows variable performance relative to the S&P500, with some periods outperforming and others underperforming.  Beta values generally range between 0.4 and 0.7, indicating lower volatility than the overall market.


**2. Recent Price Movement:**

* **Closing Price:** $170.76 (Last Market: $170.77)
* **5-Day Moving Average:** $168.94
* **20-Day Moving Average:** $167.00
* **60-Day Moving Average:** $170.02

The price is slightly above the 5-day and 60-day moving averages, suggesting a relatively stable price action. The 20-day moving average sits below, potentially suggesting some short-term weakness or consolidation.


**3. Technical Indicators and Expected Return:**

* **RSI:** 61.55 (Slightly above neutral; not overbought)
* **PPO:** 0.45 (Positive, indicating bullish momentum)
* **Relative Divergence Change (20-day):** +11.21 (Short-term upward trend)
* **Expected Return:** 0.0% (This represents the expected return relative to the S&P500 over a long-term (2+ years) horizon.  It indicates no significant outperformance expected relative to the index over this timeframe. This requires further clarification regarding the source and methodology of this figure.)

The indicators suggest a mildly bullish outlook, although the RSI is not strongly suggesting an overbought condition. The positive PPO and the positive change in relative divergence support the short-term upward trend.


**4. Recent Earnings and Outlook:**

| Date       | EPS    | Revenue (B$) |
|------------|--------|--------------|
| 2024-10-18 | 1.65   | 21.74        |
| 2024-04-19 | 1.56   | 20.20        |
| 2024-01-23 | 1.44   | 21.44        |
| 2023-10-18 | 1.89   | 21.87        |
| 2024-10-18 | 1.89   | 21.87        |

There appears to be a duplication of the 2023-10-18 data point.  EPS shows some volatility, with a recent decline from the high point of 1.89.  Revenue is relatively stable, hovering around $21B.  Further analysis is needed to compare these figures to analyst expectations and to gauge the market's reaction to this earnings data, which requires accessing external resources.


**5. Financial Information:**

The provided financial data shows relatively stable revenue and profitability with strong profit margins consistently above 50%.  Equity and ROE show some fluctuations, but generally indicate a healthy financial position.  More in-depth analysis would compare this data to industry benchmarks and historical trends for PG.


**6. News and Recent Issues:**

* **Recent Earnings News:** (Requires accessing recent news sources such as Shacknews and financial news outlets to provide a summary of recent market outlook, analyst opinions, and performance highlights. FINBOLD can also be a relevant source for this information.)
* **Recent Market Outlook:** (To be filled in based on the research of recent news and analyst reports mentioned above.)


**7.  Comprehensive Analysis:**

PG's performance has lagged the S&P 500 over the provided timeframe, although the current price action suggests some short-term stability.  Technical indicators point towards a mildly bullish outlook, but the recent earnings results show some volatility in EPS, while revenue remains relatively constant.  Further investigation into analyst expectations and market sentiment surrounding the recent earnings report is crucial for a complete evaluation. The financial data indicates a healthy financial state for the company.   A comprehensive assessment depends on a detailed review of recent market commentary and analyst opinions on the companyâ€™s outlook.


**8. Disclaimer:** This analysis is based on the limited data provided.  It should not be considered financial advice.  Conduct thorough research and consult with a financial advisor before making any investment decisions.
